References
- URL: http://www.alsuntangled.com/open.php. Accessed October 29, 2017. Archived by WebCite® at: http://www.webcitation.org/6uaDYdDIV
- URL: http://www.als.net/search/forum/?t=copper supplement. Accessed October 29, 2017. Archived by WebCite® at: http://www.webcitation.org/6uaDgIAUM
- Williams JR, Trias E, Beilby P, Lopez N, Labut E, Bradford S, et al. Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the copper-chaperone-for-SOD. Neurobiol Dis. 2016;89:1–9.
- URL: https://en.wikipedia.org/wiki/Copper_in_health#Essentiality. Accessed October 29, 2017. Archived by WebCite® at: http://www.webcitation.org/6uaDoeyyO
- Gil-Bea FJ, Aldanondo G, Lasa-Fernandez H, Lopez de Munain A, Vallejo-Illarramendi A. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis. Expert Rev Mol Med. 2017;19:e7.
- Opazo C, Greenough M, Bush A. Copper: from neurotransmission to neuroproteostasis. Front Aging Neurosci. 2014;6:143.
- Kumar N, Gross J, Ahlskpg J. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology. 2004;63:33–9.
- Weihl C, Lopate G. Motor neuron disease associated with copper deficiency. Muscle Nerve. 2006;34:789–93.
- Tokuda E, Furukawa Y. Copper homeostasis as a therapeutic target in amyotrophic lateral sclerosis with SOD1 mutations. IJMS. 2016;17:E636.
- Sinrangelo I, Ianuzzi C. The role of metal binding in the amyotrophic lateral sclerosis-related aggregation of copper-zinc superoxide dismutase. Molecules. 2017;22:1429.
- Sheng Y, Chattopadhyay M, Whitelegge J, Valentine JS. SOD1 aggregation and ALS: Role of metallation states and disulfide status. Curr Top Med Chem. 2012;12:2560–72.
- Lynch SM, Colon W. Dominant role of copper in the kinetic stability of Cu/Zn superoxide dismutase. Biochem Biophys Res Commun. 2006;340:457–61.
- Banci L, Bertini I, Ciofi-Baffoni S, Kozyreva T, Zovo K, Palumaa P. Affinity gradients driver copper to cellular destinations. Nature. 2010;465:645–8.
- Tokuda E, Okawa E, Watanabe S, Ono S, Marklund S. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities. Neurobiol Dis. 2013;54:308–19.
- Son M, Puttaparthi K, Kawamata H, Rajendran B, Boyer P, Manfredi G, et al. Overexression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. PNAS. 2007;104:6072–7.
- Vieira F, Hatzipetros T, Thompson K, Moreno A, Kidd J, Tassinari T, et al. CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits. IBRO Rep. 2017;2:47–53.
- Soon C, Donnelly P, Turner B, Hung L, Crouch P, Sherratt N, et al. Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. J Biol Chem. 2011;286:44035–44.
- Roberts B, Lim N, McAllum E, Donnelly P, Hare D, Doble P, et al. Oral treatment with CuII(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci. 2014;34:8021–31.
- McAllum E, Lim N, Hickey J, Paterson B, Donnelly B, Li Q, et al. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:586–90.
- Kurlander H, Patten M. Metals in spinal cord tissue of patients dying of motor neuron disease. Ann Neurol. 1979;6:21–4.
- Bousser M, Malier M. Penicillamine in amyotrophic lateral sclerosis. Lancet. 1979;1:168.
- Ikawa M, Okazawa H, Tsujikawa T, Matsunaga A, Yamamura O, Mori T, et al. Increased oxidative stress is related to disease severity in the ALS motor cortex: a PET study. Neurology. 2015;84:2033–9.
- URL: https://www.patientslikeme.com/treatments/show/550#overview. Accessed July 9, 2017. Archived by WebCite® at: http://www.webcitation.org/6uaGEtwzE
- URL: https://www.patientslikeme.com/treatments/show/28632. Accessed October 29 2017. Archived by WebCite® at: http://www.webcitation.org/6uaGJoL3C
- Bedlack R, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R, et al. How common are ALS plateaus and reversals? Neurology. 2016;86:808–12.
- Gibson S, Kasarskis E, Hu N, Pulst S, Mendiondo M, Matthews D, et al. Relationship of creatine kinase to body composition, disease state and longevity in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:473–7.
- URL: https://clinicaltrials.gov/ct2/show/NCT02870634?term=copper&cond=ALS&rank=3URL:https://clinicaltrials.gov/ct2/show/NCT02870634?term=copper&cond=ALS&rank=3. Accessed October 29, 2017. Archived by WebCite® at: http://www.webcitation.org/6uaGMwtUl
- O’Donohue J, Reid M, Varghese A, Portman B, Williams R. A case of adult chronic copper self-intoxication resulting in cirrhosis. Eur J Med Res. 1999;28:252.
- URL: http://https://www.amazon.com/Swanson-Swanson-SW223-Copper-300-Tabs/dp/B00068TSEK/ref=sr_1_5_a_it?ie=UTF8&qid=1509240481&sr=8-5&keywords=copper%2Bsupplement&th =1. Accessed October 29, 2017. Archived by WebCite® at: http://www.webcitation.org/6uaGQylRw
- Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, et al. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence. Am J Nucl Med Mol Imaging. 2014;4:365–84.
- Lewis J, Laforest R, Dehdashti F, Grigsby P, Welch M, Siegel B. An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix. J Nucl Med. 2008;49:1177–82.
- URL: https://www.caymanchem.com/product/17122. Accessed October 29,2017. Archived by WebCite® at: http://www.webcitation.org/6uaGTYf01